|
|
|
|
|
|
|
|
open access
"...The presence of circulating anti-AKAP4 antibodies suggests the AKAP4 is highly immunogenic in ovarian serous carcinoma patients. Our study lays the foundations for exploring AKAP4 as a potential target for the immunotherapy of ovarian cancer."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.